Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort

[1]  A. Dalhoff.  Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example , 2012, Infection.

[2]  K. Ko,et al.  Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study , 2012, Antimicrobial Agents and Chemotherapy.

[3]  B. Ledergerber,et al.  Initial management of and outcome in patients with pneumococcal bacteremia: a retrospective study at a Swiss university hospital, 2003–2009 , 2011, Infection.

[4]  D. Musher,et al.  Anemia and community-acquired pneumococcal pneumonia , 2011, Infection.

[5]  O. Vanderkooi,et al.  Factors Predicting Mortality in Invasive Pneumococcal Disease in Adults in Alberta , 2011, Medicine.

[6]  E. Cercenado,et al.  Clonal Spread of Levofloxacin-Resistant Streptococcus pneumoniae Invasive Isolates in Madrid, Spain, 2007 to 2009 , 2011, Antimicrobial Agents and Chemotherapy.

[7]  J. Y. Huh,et al.  Clinical Features of Invasive Pneumococcal Disease in Korea , 2010 .

[8]  R. George,et al.  Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England. , 2010, The Journal of antimicrobial chemotherapy.

[9]  A. von Gottberg,et al.  Molecular Characterization of Emerging Non-Levofloxacin-Susceptible Pneumococci Isolated from Children in South Africa , 2009, Journal of Clinical Microbiology.

[10]  L. López-Cerero,et al.  Fatal Levofloxacin Failure in Treatment of a Bacteremic Patient Infected with Streptococcus pneumoniae with a Preexisting parC Mutation , 2008, Journal of Clinical Microbiology.

[11]  J. Rello,et al.  Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Whitney,et al.  Levofloxacin-Resistant Invasive Streptococcus pneumoniae in the United States: Evidence for Clonal Spread and the Impact of Conjugate Pneumococcal Vaccine , 2004, Antimicrobial Agents and Chemotherapy.

[13]  K. Ko,et al.  Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. Eliopoulos.  Quinolone resistance mechanisms in pneumococci. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. Low.  Quinolone resistance among pneumococci: therapeutic and diagnostic implications. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  T. File,et al.  Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Snydman,et al.  An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  K. Klugman.  The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. , 2002, The Journal of antimicrobial chemotherapy.

[19]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[20]  Xilin Zhao,et al.  Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. , 2002, The New England journal of medicine.

[21]  L. McGee,et al.  Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. , 2002, The Journal of antimicrobial chemotherapy.

[22]  V. Cheng,et al.  Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.